Home » Stocks » Inari Medical

Inari Medical, Inc. (NARI)

Stock Price: $53.20 USD 2.26 (4.44%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 2.56B
Revenue (ttm) 71.14M
Net Income (ttm) -1.19M
Shares Out 48.18M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 10, 2020
Last Price $53.20
Previous Close $50.94
Change ($) 2.26
Change (%) 4.44%
Day's Open 50.84
Day's Range 49.46 - 54.49
Day's Volume 356,477
52-Week Range 39.55 - 54.86

More Stats

Market Cap 2.56B
Enterprise Value 2.56B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 48.18M
Float 2.20M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -1.37
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 162,709
Short Ratio 0.04
Short % of Float 0.21%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 36.03
PB Ratio n/a
Revenue 71.14M
Operating Income 801,494
Net Income -1.19M
Free Cash Flow -8.08M
Net Cash 4.55M
Net Cash / Share 0.09
Gross Margin 63.69%
Operating Margin 1.13%
Profit Margin -2.30%
FCF Margin -11.36%
ROA n/a
ROE n/a
ROIC -1.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 1
Overweight 0
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$54.25*
(1.97% upside)
Low
49.0
Current: 53.20
High
60.0
Target: 54.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018
Revenue51.136.83
Revenue Growth648.73%-
Gross Profit45.225.55
Operating Income0.80-9.14
Net Income-1.19-10.15
Shares Outstanding5.895.06
Earnings Per Share-0.20-2.01
Operating Cash Flow-4.94-10.89
Capital Expenditures-3.14-0.75
Free Cash Flow-8.08-11.64
Cash & Equivalents24.0321.88
Total Debt19.489.84
Net Cash / Debt4.5512.05
Assets44.5526.90
Liabilities29.5212.18
Book Value-39.14-39.45
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Inari Medical, Inc.
Country United States
Employees 240
CEO William H. Hoffman

Stock Information

Ticker Symbol NARI
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: NARI
IPO Date May 22, 2020

Description

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.